Skip to main content
Erschienen in: Herz 1/2023

03.01.2022 | Original articles

Effects of TCFA on stent neointimal coverage at 9 months after EXCEL drug-eluting stent implantation assessed by OCT

verfasst von: Jiao Zhang, Yuanyuan Duan, Hong Yu, Limin Jing, Yi Li, Xiaowei Jia, Dekui Jin, Huiliang Liu

Erschienen in: Herz | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to investigate the effects of thin-cap fibroatheromas (TCFAs) on stent neointimal coverage at the 9‑month follow-up after EXCEL stent implantation assessed by optical coherence tomography (OCT).

Methods

A total of 93 patients with non-ST elevation acute coronary syndrome (NSTEACS) who underwent EXCEL stent implantation were prospectively enrolled in the study and divided into a TCFA group (n = 47) and a non-TCFA group (n = 46) according to whether EXCEL stents covered the TCFAs. A TCFA was defined as a plaque with lipid content in more than one quadrant and fibrous cap thickness measuring less than 65 μm. The effect of TCFAs on stent neointimal coverage at the 9‑month follow-up after stent implantation was evaluated by OCT. The primary study endpoints were the incidence of neointimal uncoverage and stent malapposition.

Results

At the 9‑month follow-up, the minimal lumen diameter of the TCFA group tended to be smaller (2.8 ± 0.8 vs. 2.1 ± 0.8, p = 0.08) and the diameter of stenosis in the TCFA group tended to be larger (15.1 ± 10.3% vs. 26.3 ± 15.1%, p = 0.08) than those in the non-TCFA group. The mean intimal thickness of the TCFA group was significantly lower than that of the non-TCFA group (67.2 ± 35.5 vs. 145.1 ± 48.7, p < 0.001). The uncovered struts (10.1 ± 9.7 vs. 4.8 ± 4.3, p = 0.05) and malapposed struts (2.1 ± 4.7 vs. 0.3 ± 0.5, p = 0.003) in the TCFA group were more significant than those in the non-TCFA group. Multivariate analysis showed that TCFAs and lesion types were independent predictors of incomplete neointimal coverage (p < 0.05), and lesion types were independent predictors of stent malapposition (p < 0.05).

Conclusion

In patients with NSTEACS, TCFAs delayed endothelium coverage at 9 months after stent implantation, and TCFAs were independent predictors of incomplete neointimal coverage of the stent.
Literatur
1.
Zurück zum Zitat Garg S, Bourantas C, Serruys PW (2013) New concepts in the design of drug-eluting coronary stents. Nat Rev Cardiol 10(5):248–260CrossRef Garg S, Bourantas C, Serruys PW (2013) New concepts in the design of drug-eluting coronary stents. Nat Rev Cardiol 10(5):248–260CrossRef
2.
Zurück zum Zitat Minha S, Pichard AD, Waksman R (2013) In-stent restenosis of drug-eluting stents. Future Cardiol 9(5):721–731CrossRef Minha S, Pichard AD, Waksman R (2013) In-stent restenosis of drug-eluting stents. Future Cardiol 9(5):721–731CrossRef
3.
Zurück zum Zitat Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115(18):2435–2441CrossRef Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115(18):2435–2441CrossRef
4.
Zurück zum Zitat Zhang L, Wahle A, Chen Z et al (2018) Predicting locations of high-risk plaques in coronary arteries in patients receiving statin therapy. IEEE Trans Med Imaging 37(1):151–161CrossRef Zhang L, Wahle A, Chen Z et al (2018) Predicting locations of high-risk plaques in coronary arteries in patients receiving statin therapy. IEEE Trans Med Imaging 37(1):151–161CrossRef
5.
Zurück zum Zitat Cheng JM, Garcia-Garcia HM, de Boer SP et al (2014) In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J 35(10):639–647CrossRef Cheng JM, Garcia-Garcia HM, de Boer SP et al (2014) In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J 35(10):639–647CrossRef
6.
Zurück zum Zitat Iannaccone M, Quadri G, Taha S, et al (2016) Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis. Eur Heart J Cardiovasc Imaging 17 (10):1128-1137.CrossRef Iannaccone M, Quadri G, Taha S, et al (2016) Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis. Eur Heart J Cardiovasc Imaging 17 (10):1128-1137.CrossRef
7.
Zurück zum Zitat Kimura S, Sugiyama T, Hishikari K et al (2016) Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis. Int J Cardiovasc Imaging 32(10):1483–1494CrossRef Kimura S, Sugiyama T, Hishikari K et al (2016) Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis. Int J Cardiovasc Imaging 32(10):1483–1494CrossRef
8.
Zurück zum Zitat Raber L, Mintz GS, Koskinas KC et al (2018) Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European association of percutaneous cardiovascular interventions. Eur Heart J 39(35):3281–3300CrossRef Raber L, Mintz GS, Koskinas KC et al (2018) Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European association of percutaneous cardiovascular interventions. Eur Heart J 39(35):3281–3300CrossRef
9.
Zurück zum Zitat Leone AM, Rebuzzi AG, Burzotta F et al (2019) Stent malapposition, strut coverage and atherothrombotic prolapse after percutaneous coronary interventions in ST-segment elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 20(3):122–130CrossRef Leone AM, Rebuzzi AG, Burzotta F et al (2019) Stent malapposition, strut coverage and atherothrombotic prolapse after percutaneous coronary interventions in ST-segment elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 20(3):122–130CrossRef
10.
Zurück zum Zitat Im E, Lee SY, Hong SJ et al (2019) Impact of late stent malapposition after drug-eluting stent implantation on long-term clinical outcomes. Atherosclerosis 288:118–123CrossRef Im E, Lee SY, Hong SJ et al (2019) Impact of late stent malapposition after drug-eluting stent implantation on long-term clinical outcomes. Atherosclerosis 288:118–123CrossRef
11.
Zurück zum Zitat Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364(3):226–235CrossRef Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364(3):226–235CrossRef
12.
Zurück zum Zitat Torii S, Nakazawa G, Ijichi T et al (2018) Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries. Cardiovasc Interv Ther 33(1):55–61CrossRef Torii S, Nakazawa G, Ijichi T et al (2018) Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries. Cardiovasc Interv Ther 33(1):55–61CrossRef
13.
Zurück zum Zitat Poerner TC, Otto S, Gassdorf J et al (2011) A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6‑months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. EuroIntervention 7:K93–99CrossRef Poerner TC, Otto S, Gassdorf J et al (2011) A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6‑months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. EuroIntervention 7:K93–99CrossRef
14.
Zurück zum Zitat Won H, Kim JS, Shin DH et al (2014) Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography. Int J Cardiovasc Imaging 30(2):263–270CrossRef Won H, Kim JS, Shin DH et al (2014) Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography. Int J Cardiovasc Imaging 30(2):263–270CrossRef
15.
Zurück zum Zitat Baumbach A, Lansky AJ, Onuma Y et al (2018) Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET all comers. EuroIntervention 14(10):1121–1128CrossRef Baumbach A, Lansky AJ, Onuma Y et al (2018) Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET all comers. EuroIntervention 14(10):1121–1128CrossRef
16.
Zurück zum Zitat Han Z, Feng L, Du H et al (2015) Impact of age on stent strut coverage and neointimal remodeling as assessed by optical coherence tomography. Medicine 94(50):e2246CrossRef Han Z, Feng L, Du H et al (2015) Impact of age on stent strut coverage and neointimal remodeling as assessed by optical coherence tomography. Medicine 94(50):e2246CrossRef
17.
Zurück zum Zitat Nakata T, Fujii K, Fukunaga M et al (2016) Morphological, functional, and biological vascular healing response 6 months after drug-eluting stent implantation: a randomized comparison of three drug-eluting stents. Catheter Cardiovasc Interv 88(3):350–357CrossRef Nakata T, Fujii K, Fukunaga M et al (2016) Morphological, functional, and biological vascular healing response 6 months after drug-eluting stent implantation: a randomized comparison of three drug-eluting stents. Catheter Cardiovasc Interv 88(3):350–357CrossRef
18.
Zurück zum Zitat Tang L, Cui QW, Liu DP et al (2019) The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention. Medicine 98(50):e18312CrossRef Tang L, Cui QW, Liu DP et al (2019) The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention. Medicine 98(50):e18312CrossRef
19.
Zurück zum Zitat Valgimigli M, Tebaldi M, Borghesi M et al (2014) Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY). JACC Cardiovasc Interv 7(1):20–28CrossRef Valgimigli M, Tebaldi M, Borghesi M et al (2014) Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY). JACC Cardiovasc Interv 7(1):20–28CrossRef
20.
Zurück zum Zitat Xu K, Han Y, Xu B et al (2018) Efficacy and safety of a second-generation biodegradable polymer sirolimus-eluting stent: one-year results of the CREDIT 2 trial. Cardiovasc Ther 36(3):e12327CrossRef Xu K, Han Y, Xu B et al (2018) Efficacy and safety of a second-generation biodegradable polymer sirolimus-eluting stent: one-year results of the CREDIT 2 trial. Cardiovasc Ther 36(3):e12327CrossRef
21.
Zurück zum Zitat Jin ZG, Liu HL, Luo JP et al (2011) Long-term effects of biodegradable versus durable polymer-coated sirolimus-eluting stents on coronary arterial wall morphology assessed by virtual histology intravascular ultrasound in patients with acute coronary syndrome. Heart 97(3):A166–A166 Jin ZG, Liu HL, Luo JP et al (2011) Long-term effects of biodegradable versus durable polymer-coated sirolimus-eluting stents on coronary arterial wall morphology assessed by virtual histology intravascular ultrasound in patients with acute coronary syndrome. Heart 97(3):A166–A166
22.
Zurück zum Zitat Kubo T, Maehara A, Mintz GS et al (2010) Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. Am Heart J 159(2):271–277CrossRef Kubo T, Maehara A, Mintz GS et al (2010) Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. Am Heart J 159(2):271–277CrossRef
23.
Zurück zum Zitat Prati F, Di Vito L, Biondi-Zoccai G et al (2012) Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’Infarto-optimisation of percutaneous coronary intervention (CLI-OPCI) study. EuroIntervention 8(7):823–829CrossRef Prati F, Di Vito L, Biondi-Zoccai G et al (2012) Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’Infarto-optimisation of percutaneous coronary intervention (CLI-OPCI) study. EuroIntervention 8(7):823–829CrossRef
24.
Zurück zum Zitat Kim BK, Shin DH, Kim JS et al (2012) Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation. Int J Cardiovasc Imaging 28(8):1887–1894CrossRef Kim BK, Shin DH, Kim JS et al (2012) Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation. Int J Cardiovasc Imaging 28(8):1887–1894CrossRef
25.
Zurück zum Zitat Guagliumi G, Costa MA, Sirbu V et al (2011) Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial. Circulation 123(3):274–281CrossRef Guagliumi G, Costa MA, Sirbu V et al (2011) Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial. Circulation 123(3):274–281CrossRef
26.
Zurück zum Zitat Farb A, Burke AP, Kolodgie FD et al (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108(14):1701–1706CrossRef Farb A, Burke AP, Kolodgie FD et al (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108(14):1701–1706CrossRef
27.
Zurück zum Zitat Kubo T, Imanishi T, Kitabata H et al (2008) Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging 1(4):475–484CrossRef Kubo T, Imanishi T, Kitabata H et al (2008) Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging 1(4):475–484CrossRef
Metadaten
Titel
Effects of TCFA on stent neointimal coverage at 9 months after EXCEL drug-eluting stent implantation assessed by OCT
verfasst von
Jiao Zhang
Yuanyuan Duan
Hong Yu
Limin Jing
Yi Li
Xiaowei Jia
Dekui Jin
Huiliang Liu
Publikationsdatum
03.01.2022
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 1/2023
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-021-05095-2

Weitere Artikel der Ausgabe 1/2023

Herz 1/2023 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.